MedTrace Logo

Autologous Muscle Derived Stem Cells Transplantation in Urine Incontinency

NCT01963455 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-05-06

No results posted yet for this study

Summary

This study was designed to provide confirmation of safety of muscle derived cell (MDCs) for the treatment of stress urine incontinency (SUI) in women.

Conditions

  • Stress Incontinency

Interventions

BIOLOGICAL

paraurethral injection of MDCs

MDCs transplantation by paraurethral injection .

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Nasser Aghdami, MD,PhD · Head of Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology

  • Farzaneh Sharifiaghdas, MD · Urology and Nephrology Research Center, Shahid Beheshti University

  • Reza Moghadasali, PhD · Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology

  • Farzam Tajali, MD · Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01963455 on ClinicalTrials.gov